Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPURE.L Regulatory News (PURE)

  • There is currently no data for PURE

LTIP Options

22 Jul 2011 07:00

RNS Number : 8480K
PureCircle Limited
22 July 2011
 



 

PURECIRCLE LIMITED

("PureCircle" or the "Company")

 

Transfer of Treasury shares to satisfy exercise of LTIP Options

 

 

PureCircle (LSE:PURE), the world's largest producer and marketer of high purity stevia, announces the transfer on Thursday 21 July 2011 of 249,227 ordinary shares from treasury stock to satisfy the vesting and exercise of options granted under the Company's Long Term Incentive Plan (LTIP).

 

One hundred and eighty one thousand (181,000) of the Options exercised were by employees at a $Nil exercise price.

 

Sixty eight thousand two hundred and twenty seven (68,227) of the Options exercised were by Directors, including an Executive Director, all at an exercise price of GBP1.50 (US$2.40) per share.

 

Details of the options exercised by Directors were:

 

- Mr P Lai (Non Executive) 21,500

- Mr O Maes (Non Executive) 14,000

- Mr W Mitchell (Executive) 20,227

- Mr J Slosar (Non Executive) 12,500

 

 

The Options exercised were satisfied from a transfer of the Company's existing Treasury shares of 322,250 shares. The remaining seventy three thousand and twenty three (73,023) shares will continue to be held as Treasury shares pending the exercise of further Options already granted under the Long Term Incentive Plan (LTIP).

 

 

 

Enquiries:

PureCircle Limited (www.purecircle.com)

Magomet Malsagov, CEO

+60 1 2388 8049

William Mitchell, CFO

+44 7974 005 163

RFC Corporate Finance (NOMAD)

+61 8 9480 2500

Steve Allen

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCRBMITMBATBPB
Date   Source Headline
29th Oct 20097:00 amRNSProduct Launch
27th Oct 200912:35 pmRNSHolding(s) in Company
21st Oct 20097:00 amRNSPureCircle and PepsiCo to receive Scientific Excel
20th Oct 20097:00 amRNSProduct Launch
15th Oct 200910:00 amRNSTrading Statement
8th Oct 20097:00 amRNSDirector Declaration
23rd Sep 20097:00 amRNSFinal Results
8th Sep 20098:32 amRNSStatement re Approval
4th Sep 20093:00 pmRNSStatement re Shareholding
2nd Sep 200910:10 amRNSChange of Adviser
8th Jul 20097:00 amRNSTrading Update
15th Jun 20098:41 amRNSNotification of a Major Interest
27th Apr 20097:02 amRNSCompletion of Extract Plant Complex
1st Apr 20097:00 amRNSDealings in Shares
5th Mar 20099:20 amRNSDirector's Dealing
4th Mar 20097:00 amRNSHalf Yearly Report
29th Jan 20097:00 amRNSSENIOR INTERNATIONAL SALES TEAM APPOINTMENT
19th Jan 20097:00 amRNSAppointment
13th Jan 20097:00 amRNSAppointment of Head of PureCircle USA
12th Jan 20097:09 amRNSNotice of Results
6th Jan 20097:00 amRNSStrategic Global Collaboration
5th Jan 20097:00 amRNSDirector Dealings
18th Dec 20087:00 amRNSRegulatory Approval
24th Nov 20087:51 amRNSExecutive Management Appointments
10th Nov 20087:55 amRNSIssuance of Options
7th Nov 20089:51 amRNSExercise of Options
17th Oct 20083:05 pmRNSDealings in shares
15th Oct 20087:00 amRNSFinal Results
13th Oct 200812:58 pmRNSBoard Change
10th Oct 20089:44 amRNSApproval Announced
22nd Aug 20087:00 amRNSRevised Results Day
20th Aug 20088:42 amRNSBoard Appointment
31st Jul 20083:42 pmRNSMajor contract win
21st Jul 20088:45 amRNSNotice of Interim Results
2nd Jul 20088:10 amRNSRe Share Holdings
2nd Jul 20087:03 amRNSDirector's Dealings
1st Jul 20081:08 pmRNSStrategic Partnership
16th Jun 20088:34 amRNSLong Term Incentive Plan
2nd Jun 20089:27 amRNSAGM and Board appointments
2nd Jun 20087:00 amRNSDealings in Shares
20th May 20089:08 amRNSCompletion of aquisition and
9th May 20088:39 amRNSNotice of AGM
7th May 20087:00 amRNSAppointment
6th May 20088:33 amRNSKenya Joint Venture
22nd Apr 200811:19 amRNSInvestor Presentation
7th Apr 20088:37 amRNSAcquisition
1st Apr 20087:01 amRNSFinal Results
31st Mar 20089:19 amRNSNotification re: results
10th Mar 20081:16 pmRNSResults Date
28th Feb 20088:43 amPRNHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.